Glipizide XL 10mg Tablets
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. Take your dose with your first meal of the day. Swallow the tablet whole - do not chew, break, crush, or dissolve it. If you have a change in your eating habits or skip a meal, be sure to understand how to adjust your medication schedule accordingly.
Storing and Disposing of Your Medication
Keep your medication at room temperature in a dry place, avoiding storage in a bathroom. Store the medication in its original container to maintain its effectiveness. It is essential to keep all medications in a safe location, out of the reach of children and pets, to prevent accidental ingestion.
Missing a Dose
If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses, as this may increase the risk of side effects.
Lifestyle & Tips
- Take Glipizide XL once daily with breakfast to help it work best and reduce the risk of low blood sugar.
- Follow a healthy diet plan recommended by your doctor or dietitian.
- Engage in regular physical activity as advised by your healthcare provider.
- Monitor your blood sugar levels regularly as instructed by your doctor.
- Carry a source of fast-acting sugar (e.g., glucose tablets, hard candy, fruit juice) to treat low blood sugar.
- Limit or avoid alcohol consumption, as it can increase the risk of low blood sugar and other side effects.
Available Forms & Alternatives
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Changes in eyesight
Slurred speech
Tingling
Fever, chills, or sore throat
Unexplained bruising or bleeding
Feeling extremely tired or weak
Symptoms of low blood sugar, which may include:
+ Dizziness
+ Headache
+ Feeling sleepy or weak
+ Shaking
+ Fast heartbeat
+ Confusion
+ Hunger
+ Sweating
If you experience any of these symptoms, follow your doctor's instructions for managing low blood sugar, which may include taking glucose tablets, liquid glucose, or some fruit juices.
Other Possible Side Effects
Like all medications, this drug can cause side effects. Although many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor or seek medical help:
Dizziness
Diarrhea
Feeling nervous and excitable
Gas
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Symptoms of low blood sugar (hypoglycemia): sweating, shaking, dizziness, confusion, hunger, irritability, blurred vision, headache, rapid heartbeat. If these occur, consume a fast-acting sugar source immediately.
- Symptoms of high blood sugar (hyperglycemia): increased thirst, increased urination, fatigue, blurred vision. Report these to your doctor.
- Signs of allergic reaction: rash, itching, swelling (especially of the face, tongue, or throat), severe dizziness, trouble breathing. Seek immediate medical attention.
- Unusual weight gain or swelling.
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced.
A known sulfa allergy.
Any narrowing of the gastrointestinal (GI) tract or a history of bowel blockage.
Acidic blood conditions, such as those that affect your blood's pH balance.
* If you have type 1 diabetes, as this medication is not intended to treat this condition.
This list is not exhaustive, and it is crucial to discuss all your medications, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins, with your doctor and pharmacist. They will help you determine if it is safe to take this medication with your existing treatments and health conditions. Never start, stop, or adjust the dosage of any medication without first consulting your doctor to ensure your safety.
Precautions & Cautions
Regular blood tests will be necessary, as directed by your doctor. Be sure to discuss any concerns or questions with your doctor during these appointments. Additionally, inform all healthcare providers and laboratory personnel that you are taking this medication, as it may impact certain lab test results.
Adhere to the diet and exercise plan recommended by your doctor. If you experience low blood sugar, avoid driving, as this increases the risk of accidents. It is also recommended to avoid consuming alcohol while taking this medication. If you are taking colesevelam, take it at least 4 hours after taking this drug.
Be aware that stress, such as fever, infection, injury, or surgery, can affect blood sugar control. Changes in physical activity, exercise, or diet may also impact blood sugar levels. If you have a deficiency of the enzyme G6PD, exercise caution, as you may be more prone to anemia. This enzyme deficiency is more common in individuals of African, South Asian, Middle Eastern, and Mediterranean descent.
There is an increased risk of heart disease-related death associated with this medication. Discuss this risk with your doctor. Low blood sugar is a potential side effect, and severe cases can lead to seizures, loss of consciousness, long-term brain damage, and even death. Consult your doctor if you experience any symptoms of low blood sugar.
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects. Inform your doctor if you are pregnant, plan to become pregnant, or are breastfeeding, as the benefits and risks to you and the baby need to be discussed.
You may notice the tablet shell in your stool, but this is a normal occurrence and not a cause for concern. However, if you take this medication during pregnancy, you may need to stop taking it before your due date, as low blood sugar has been reported in infants born to mothers who took similar medications. Consult your doctor for guidance on managing this risk.
Overdose Information
Overdose Symptoms:
- Severe hypoglycemia (extremely low blood sugar)
- Confusion
- Slurred speech
- Seizures
- Loss of consciousness
- Coma
What to Do:
In case of suspected overdose, seek immediate medical attention. For conscious patients, administer oral glucose. For unconscious patients, administer intravenous glucose (dextrose) or glucagon. Prolonged observation in a hospital setting is often required due to the extended-release nature and potential for recurrent hypoglycemia. Call 1-800-222-1222 (Poison Control).
Drug Interactions
Contraindicated Interactions
- Bosentan (increased risk of hepatotoxicity)
- Miconazole (oral, severe hypoglycemia)
Major Interactions
- Alcohol (disulfiram-like reaction, severe hypoglycemia)
- Beta-blockers (mask hypoglycemia symptoms, impair glucose recovery)
- Fluconazole (increased glipizide levels, hypoglycemia)
- NSAIDs (increased glipizide levels, hypoglycemia)
- Sulfonamides (increased glipizide levels, hypoglycemia)
- Chloramphenicol (increased glipizide levels, hypoglycemia)
- Probenecid (increased glipizide levels, hypoglycemia)
- MAOIs (increased glipizide levels, hypoglycemia)
- Warfarin (altered anticoagulant effect, monitor INR)
Moderate Interactions
- Cimetidine (increased glipizide levels, hypoglycemia)
- Diuretics (thiazides, loop diuretics - may cause hyperglycemia)
- Corticosteroids (may cause hyperglycemia)
- Thyroid products (may cause hyperglycemia)
- Estrogens/Oral Contraceptives (may cause hyperglycemia)
- Phenytoin (may cause hyperglycemia)
- Nicotinic acid (may cause hyperglycemia)
- Sympathomimetics (may cause hyperglycemia)
- Calcium channel blockers (may cause hyperglycemia)
- Isoniazid (may cause hyperglycemia)
- Rifampin (decreased glipizide levels, hyperglycemia)
- Colesevelam (decreased glipizide absorption, administer glipizide 4 hours before)
Minor Interactions
- Not available
Monitoring
Baseline Monitoring
Rationale: To establish baseline glycemic control and guide initial therapy.
Timing: Prior to initiation of therapy.
Rationale: To establish baseline glycemic control and guide initial therapy.
Timing: Prior to initiation of therapy.
Rationale: To assess kidney function, as glipizide is primarily renally excreted and renal impairment increases hypoglycemia risk.
Timing: Prior to initiation of therapy.
Rationale: To assess liver function, as glipizide is metabolized in the liver and hepatic impairment increases hypoglycemia risk.
Timing: Prior to initiation of therapy.
Routine Monitoring
Frequency: Every 3-6 months
Target: <7% (individualized)
Action Threshold: If target not met, consider dose adjustment or addition of other agents.
Frequency: Daily (self-monitoring) or weekly (clinic)
Target: 80-130 mg/dL (individualized)
Action Threshold: Persistent readings outside target range may indicate need for dose adjustment.
Frequency: Daily, patient self-monitoring
Target: N/A
Action Threshold: Any symptoms of hypoglycemia (e.g., sweating, tremor, confusion) require immediate action (consume glucose) and dose review.
Frequency: Annually or as clinically indicated
Target: N/A
Action Threshold: Significant decline may necessitate dose reduction or discontinuation.
Frequency: Annually or as clinically indicated
Target: N/A
Action Threshold: Significant elevation may necessitate dose reduction or discontinuation.
Symptom Monitoring
- Symptoms of hypoglycemia (e.g., sweating, tremor, dizziness, confusion, hunger, irritability, blurred vision, headache, rapid heartbeat)
- Symptoms of hyperglycemia (e.g., increased thirst, increased urination, fatigue, blurred vision)
- Signs of allergic reaction (e.g., rash, itching, swelling)
- Gastrointestinal upset (e.g., nausea, diarrhea, constipation)
Special Patient Groups
Pregnancy
Category C. Not recommended for use during pregnancy. Insulin is generally preferred for glycemic control in pregnant women with diabetes due to the potential for fetal hyperinsulinemia and neonatal hypoglycemia with sulfonylureas.
Trimester-Specific Risks:
Lactation
Excreted into breast milk. Not recommended during breastfeeding due to the potential for hypoglycemia in the breastfed infant.
Pediatric Use
Safety and effectiveness have not been established in pediatric patients. Not recommended for use in children.
Geriatric Use
Use with caution in elderly patients due to increased risk of hypoglycemia, particularly in those with impaired renal or hepatic function. Start with a lower dose (e.g., 2.5 mg daily) and titrate slowly. Monitor blood glucose closely.
Clinical Information
Clinical Pearls
- Always take Glipizide XL with breakfast to ensure optimal absorption and reduce the risk of hypoglycemia.
- Patients should be educated on the symptoms of hypoglycemia and how to treat it immediately.
- Weight gain is a common side effect of sulfonylureas.
- Not effective in patients with Type 1 diabetes or diabetic ketoacidosis (DKA) as it requires functioning pancreatic beta cells.
- Caution is advised in patients with G6PD deficiency due to the risk of hemolytic anemia with sulfonylureas.
- Regular monitoring of blood glucose and HbA1c is crucial to assess efficacy and safety.
Alternative Therapies
- Metformin (Biguanide)
- DPP-4 inhibitors (e.g., Sitagliptin, Saxagliptin)
- SGLT2 inhibitors (e.g., Canagliflozin, Dapagliflozin)
- GLP-1 receptor agonists (e.g., Liraglutide, Semaglutide)
- Thiazolidinediones (e.g., Pioglitazone, Rosiglitazone)
- Meglitinides (e.g., Repaglinide, Nateglinide)
- Insulin therapy